tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Advertisement

Editas Medicine (EDIT) Similar Stocks

Compare
3,529 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$3.96
$365.08M
19.64%
5 Buy
5 Hold
2 Sell
Hold
Cellectis SA
$4.52
$304.57M
136.65%
1 Buy
1 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$4.42
$249.86M
-45.50%
3 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$10.60
$173.19M
110.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$30.22
$206.74M
102.65%
3 Buy
0 Hold
0 Sell
Strong Buy
Caribou Biosciences
$2.84
$264.47M
37.63%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
3.96
0.65
19.64%
CLLS
Cellectis SA
4.52
2.61
136.65%
FHTX
Foghorn Therapeutics
4.42
-3.32
-42.89%
ELTX
Elicio Therapeutics
10.05
5.28
110.69%
VOR
Vor Biopharma
29.06
14.72
102.65%
CRBU
Caribou Biosciences
2.67
0.73
37.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis